Cargando…
Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab
Hypereosinophilic dermatitis (HED) is a subtype of hypereosinophilic syndrome. HED is characterized by eosinophilic granulocytes increased in peripheral blood and bone marrow and infiltrated in skin. The clinical manifestations of HED are diffussed by erythema, papule and maculopapule with severe it...
Autores principales: | Wu, Chenyu, Zhang, Jianzhong, Zhao, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124617/ https://www.ncbi.nlm.nih.gov/pubmed/37101561 http://dx.doi.org/10.2147/BTT.S400073 |
Ejemplares similares
-
A case of complete recovery in a hypereosinophilic dermatitis patient with dupilumab
por: Jiang, Xiaoyun, et al.
Publicado: (2023) -
Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome
por: Du, Xiaoman, et al.
Publicado: (2022) -
Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment
por: Wieser, Jill K., et al.
Publicado: (2020) -
Successful Treatment of an Adult with Atopic Dermatitis and Lamellar Ichthyosis Using Dupilumab
por: Binkhonain, Faisal K, et al.
Publicado: (2022) -
Successful treatment of lichen amyloidosis coexisting with atopic dermatitis by dupilumab: Four case reports
por: Zhu, Qing, et al.
Publicado: (2023)